Please provide your email address to receive an email when new articles are posted on . Predicting treatment risk using geriatric assessment and genetic profiling for AML may impact early rates of ...
In this webinar, Zivjena Vucetic will discuss how single-cell sequencing improves measurable residual disease detection (MRD) ...
A patient assessment tool, known as the Functional Assessment of Cancer Therapy–Leukemia (FACT-Leu), was a viable and valid outcome measure for patients with acute myeloid leukemia not eligible for ...
GlobalData has released its pharmaceutical report, "Acute Myeloid Leukemia (AML) - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on ...
Add to Calendar: Add to Calendar: 2021-09-23 19:00:00 2021-09-23 20:00:00 Integrating a Risk Assessment into an AML Program Event Description The FATF recommendations and regulators encourage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results